Abstract
Pre-hematopoietic stem cell transplantation (HSCT) dental treatment is essential to prevent serious infections from oral sources during immunosuppression, in patients who undergo HSCT therapy. This study was planned to establish a dental management protocol for such patients. Forty-one patients scheduled for HSCT to treat hematological malignancies were consecutively enrolled in the prospective trial. The dental status of all patients was evaluated by clinical and radiographic examination at a median of 47 days before the commencement of HSCT therapy. Thirty-six patients had one or more dental diseases; the remaining five had none. Caries was found in 26 patients, apical periodontitis in 19, marginal periodontitis in 24 and a partially erupted third molar in 11. Our policy is to preserve patients' teeth whenever possible, and therefore minimal dental intervention was planned. Treatment was completed for all 36 patients with dental pathologies, before the conditioning regimen began. All patients received the scheduled HSCT therapy without alteration, interruption or delay, and did not show any signs or symptoms associated with odontogenic infection while they were immunosuppressed. This protocol, therefore, appears to be appropriate for the pre-HSCT dental treatment of patients with hematological diseases.
Similar content being viewed by others
References
Bortin MM, Horowitz MM, Gale RP, Barrett AJ, Champlin RE, Dicke KA et al. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA 1992; 268: 607–612.
Appelbaum FR . Use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin 1996; 46: 142–164.
Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infection among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000; 49: 1–128.
Overholser CD . Periodontal infection in patients with acute non-lymphocytic leukemia: prevalence of acute exacerbations. Arch Intern Med 1982; 142: 551–554.
Sonis S, Kunz A . Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies. Oral Surg Oral Med Oral Pathol 1998; 65: 19–22.
Peterson DE . Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr 1990; 9: 61–71.
Barker GJ . Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation. Support Care Cancer 1999; 7: 17–20.
National Institutes of Health Consensus. Development panel. Consensus statement: oral complications of cancer therapy. NCI Monogr 1990; 9: 3–8.
Heimdahl A, Mattsson T, Dahllof G, Lonnquist B, Ringden O . The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1989; 68: 711–716.
Bergmann O . Oral infections and septicemia in immunocompromised patients with hematologic malignancies. J Clin Microbiol 1988; 26: 2105–2109.
Melkos AB, Massenkeil G, Arnold R, Reichart PA . Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome. Clin Oral Invest 2003; 7: 113–115.
Toljanic JA, Bedard JF, Larson RA, Fox JP . A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer. Cancer 1999; 85: 1843–1848.
Elad S, Garfunkel AA, Or R, Michaeli E, Shapira MY, Galili D . Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients. Support Care Cancer 2003; 11: 674–677.
Yamagata K, Onizawa K, Yoshida H, Hasegawa Y, Nagasawa T . Dental management of patients before bone marrow transplantation. Jpn J Transplant 1998; 34: 22–26 (abstract in English).
Akintoye SO, Brennan MT, Graber CJ, Mckinney BE, Rams TE, Barret AJ et al. A retrospective investigation of advanced periodontal disease as a risk for septicemia in hematopoietic stem cell and bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 581–588.
Barasch A, Mosier KM, Ambrosion JAD, Giniger MS, Ascensao J, Peterson DE . Postextraction osteomyelitis in a bone marrow transplant recipient. Oral Surg Oral Med Oral Pathol 1993; 75: 391–396.
Tai CCE, Precious DS, Wood RE . Prophylactic extraction of third molars in cancer patients. Oral Surg Oral Med Oral Pathol 1994; 78: 151–155.
Overholser CD, Peterson DE, Bergman SA, Williams LT . Dental extraction in patients with acute nonlymphocytic leukemia. J Oral Maxillofac Surg 1982; 40: 296–298.
Peters E, Monopoli M, Woo SB, Sonis S . Assessment of the need for treatment of postendodontic asymptomatic periapical radiolucencies in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 1993; 76: 45–48.
Raut A, Huryn JM, Hwang FR, Zlotolow IM . Sequelae and complications related to dental extractions in patients with hematologic malignancies and the impact on medical outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 49–55.
Majorana A, Schubert MM, Porta F, Ugazaio AG, Sapelli PL . Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management. Support Care Cancer 2000; 8: 353–365.
Maxymiw WG, Wood RE . The role of dentistry in patients undergoing bone marrow transplantation. Br Dent J 1989; 167: 229–233.
Lazarchik DA, Filler SJ, Winkler MP . Dental evaluation in bone marrow transplantation. Gen Dent 1995; 43: 369–371.
Sonis ST, Woods PD, White BA . Pretreatment oral assessment. NCI Monogr 1990; 9: 29–32.
Carl W . Bone marrow transplants and oral complications. Quintessence Int 1984; 10: 1001–1009.
Mercier P, Precious D . Risks and benefits of removal of impacted third molars. Int J Oral Maxillofac Surg 1992; 21: 17–27.
Bruce RA, Frederickson GC, Small GS . Age of patients and morbidity associated with mandibular third molar surgery. J Am Dent Assoc 1980; 101: 240–245.
Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M . Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial comparing two protocols of dental care. Eur J Cancer B 1994; 30: 93–97.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamagata, K., Onizawa, K., Yanagawa, T. et al. A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation. Bone Marrow Transplant 38, 237–242 (2006). https://doi.org/10.1038/sj.bmt.1705429
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705429
- Springer Nature Limited
Keywords
This article is cited by
-
Do oral conditions influence the incidence of bloodstream infection after hematopoietic stem cell transplantation? A retrospective study in Japan
Supportive Care in Cancer (2024)
-
Oral colonization by gram-negative bacilli in patients with hematologic malignancies and solid tumors compared with healthy controls
BMC Oral Health (2023)
-
Oral microbial changes and oral disease management before and after the treatment of hematological malignancies: a narrative review
Clinical Oral Investigations (2023)
-
Clinical utility of oral management in allogeneic hematopoietic stem cell transplantation recipients: microbiological evidence based on molecular analysis of oral bacteria
Supportive Care in Cancer (2022)
-
Effectiveness of glass ionomer cements in the restorative treatment of radiation-related caries — a systematic review
Supportive Care in Cancer (2022)